Literature DB >> 9562240

An accessory role for ceramide in interleukin-1beta induced prostaglandin synthesis.

K Kirtikara1, S J Laulederkind, R Raghow, T Kanekura, L R Ballou.   

Abstract

Interleukin-1beta (IL-1) is a potent inducer of prostaglandin E2 (PGE2) synthesis. We previously showed that ceramide accumulates in fibroblasts treated with IL-1 and that it enhances IL-1-induced PGE2 production. The present study was undertaken to determine the mechanism(s) by which ceramide and IL-1 interact to enhance PGE2 production by examining their respective effects on the rate-limiting enzymes in PGE2 synthesis, cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A2 (cPLA2). IL-1-induced PGE2 synthesis required approximately 8 h even though COX-1 was constitutively expressed (both mRNA and protein) and enzymatically active in untreated cells. Conversely, COX-2 mRNA was barely detectable in untreated cells but within 2 h, ceramide or IL-1 alone induced a 5 and 20 fold increase in COX-2 mRNA, respectively. However, IL-1 induced COX-2 protein synthesis was only detectable 6-7 h after maximal COX-2 mRNA induction; COX-2 protein accumulation was not induced by ceramide alone. Ceramide however, reduced the length of time required for IL-1 to induce COX-2 protein accumulation and increased COX-2 protein accumulation. IL-1 induced a 15 fold increase in COX-1 mRNA including an alternatively spliced form of COX-1. IL-1, but not ceramide induced cPLA2 mRNA and protein expression which corresponded with the initiation of PGE2 synthesis. These observations indicate that, (1) while either ceramide or IL-1 rapidly induced COX-2 mRNA, COX-2 protein only accumulated in IL-1 treated cells after a delay of 6-7 h, (2) IL-1-induced PGE2 synthesis required both COX-2 and cPLA2 protein synthesis and, (3) ceramide enhanced (temporally and quantitatively) IL-1-induced COX-2 protein

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562240     DOI: 10.1023/a:1006824009546

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Authors:  S H Lee; E Soyoola; P Chanmugam; S Hart; W Sun; H Zhong; S Liou; D Simmons; D Hwang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid.

Authors:  L L Lin; A Y Lin; J L Knopf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells.

Authors:  M Murakami; J F Penrose; Y Urade; K F Austen; J P Arm
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

4.  NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

Authors:  N Futaki; K Yoshikawa; Y Hamasaka; I Arai; S Higuchi; H Iizuka; S Otomo
Journal:  Gen Pharmacol       Date:  1993-01

5.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells.

Authors:  M K Reiger; D L DeWitt; M S Schindler; W L Smith
Journal:  Arch Biochem Biophys       Date:  1993-03       Impact factor: 4.013

7.  Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells.

Authors:  M J Holtzman; J Turk; L P Shornick
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

8.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

9.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

Authors:  D A Jones; D P Carlton; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more
  5 in total

1.  Exogenous expression of Msx1 renders myoblasts refractory to differentiation into myotubes and elicits enhanced biosynthesis of four unique mRNAs.

Authors:  S Thompson-Jaeger; R Raghow
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells.

Authors:  Z Zhang; H Sheng; J Shao; R D Beauchamp; R N DuBois
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

3.  Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements.

Authors:  K Kirtikara; R Raghow; S J Laulederkind; S Goorha; T Kanekura; L R Ballou
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 4.  Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

Authors:  O C Trifan; T Hla
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

5.  Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway.

Authors:  Bing-Chang Chen; Huey-Mei Chang; Ming-Jen Hsu; Chwen-Ming Shih; Yi-Hua Chiu; Wen-Ta Chiu; Chien-Huang Lin
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.